开发一种针对Helicobacter pylori的有效疫苗:关键考虑和挑战
Faria Hasanzadeh Haghighi1, Shaho Menbari1,2, Roghayeh Mohammadzadeh1
1Department of Microbiology and Virology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Expert reviews in molecular medicine
|November 25, 2024
概括
由于抗生素耐药性,开发针对Helicobacter pylori (H. pylori) 的疫苗至关重要. 本综述涵盖了创建有效的H. pylori疫苗的关键考虑因素,包括抗原,辅助剂,分娩和动物模型.
科学领域:
- 微生物学和免疫学
- 疫苗开发 疫苗开发
- 胃肠病学 胃肠病学
背景情况:
- 杆菌 (H. pylori) 感染是全球胃癌和胃潰瘍的主要原因之一.
- 对H. pylori的抗生素治疗由于抗药性增加而变得越来越不有效,导致治疗失败和再感染.
- 迫切需要采取替代策略,如疫苗接种,以对抗H. pylori感染.
研究的目的:
- 审查设计有效的H. pylori疫苗的基本组成部分.
- 讨论抗原,辅助剂,疫苗输送系统和动物模型的选择标准.
- 突出开发一种强效的H. pylori疫苗所面临的挑战和考虑因素.
主要方法:
- 关于H. pylori,宿主免疫反应和疫苗开发策略的现有研究的文献综述.
- 分析影响疫苗有效性的因素,包括抗原选择,辅助性质和输送方法.
- 对适合用于H. pylori疫苗临床前试验的动物模型的评估.
主要成果:
- 最佳的疫苗配方需要仔细考虑免疫原抗原和有效的辅助剂,以刺激强大的宿主免疫反应.
- 疫苗输送系统的选择会影响免疫性和患者的服药性.
- 适当的动物模型对于预测疫苗在人类中的有效性至关重要.
结论:
- 开发成功的H. pylori疫苗需要全面了解细菌病原性和宿主免疫力.
- 疫苗组件 (抗原,辅助剂,输送系统) 和临床前模型的战略选择至关重要.
- 克服疫苗设计方面的挑战是为H. pylori感染提供安全有效的抗生素治疗替代方案的关键.
相关概念视频
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
328
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
328
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
89
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
89
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
356
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
356
01:26Peptic Ulcer Disease IV: Management
74
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
74
01:23Gastritis III: Clinical Manifestations and Management
158
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
158
01:29Microorganisms in Medicine and Therapeutics
1
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1